{"id": "1381411749732085761", "creation": 1618189201.0, "user_id": "1211892441529241601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 2, "reply_count": 0, "like_count": 3, "quote_count": 1}}, "text": "The new #recombinant #COVID19 #vaccine, developed by the National Vaccine &amp;Serum Institute, a R&amp;D center of #Sinopharm's bioscience subsidiary the #China National Biotec Group, got approval from the National Medical Products Administration on Apr. 9. https://t.co/c0pkFa6uVF", "first_save": 1634559108.199414, "hashtags": ["#RECOMBINANT", "#COVID19", "#VACCINE", "#SINOPHARM", "#CHINA"]}